Virtual workouts tested to beat cancer fatigue

NCT ID NCT07243834

Recruiting now Symptom relief Sponsor: Royal Marsden NHS Foundation Trust Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a digital exercise program with online group sessions can help prostate cancer patients on hormone therapy exercise more regularly. 160 participants will either get standard care or standard care plus the digital program. Adherence is tracked with a wearable device and diaries over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: digital exercise intervention with virtual supervised group exercise sessions
What this could lead to: If successful, this could offer a convenient way for prostate cancer patients to stay active during hormone therapy, reducing side effects like fatigue and muscle loss.
What could go wrong: This is a single-center trial with 160 participants, so results may not apply broadly. Exercise adherence may still be low despite the digital format, and the study does not test a drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease Motor Activity prostate adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER PROSTATE CANCER (DIAGNOSIS)

Contacts and locations

Locations

The Royal Marsden Hospital
RECRUITING

London, SW3 6JJ, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.